investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Exploration of a Mutant p53 Reactivating Compound
Darren Richard Carpizo
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Darren Richard Carpizo
Rutgers University
New Brunswick, United States
Related projects
Geulah Yevgeniya Livshits
Mechanisms of tumor suppression by epigenetic regulators in pancreatic cancer
Pancreas
Gregory J Hannon
Cold Spring Harbor Laboratory Cancer Research Center
Pancreas
Udo Rudloff
Preclinical Drug Development in Pancreatic Cancer
Pancreas
Pathology
Peter Kraft
Leveraging GxE interaction to understand pancreatic cancer and altered metabolism
Pancreas
Mircea Ivan
Role of Hypoxia-Induced miR-210 in Tumor Metabolism
Pancreas
Lino Tessarollo
Role of Neurotrophins in the Development of the Mammalian Nervous System
Pancreas
Kathleen M Mulder
Directional Motility and ERM Scaffolding in Pathfinder Pancreatic Carcinoma Cells
Pancreas
Pathology
Eric Collisson
A Genetically Defined System to Identify Factors Essential for KRas Oncogenesis
Pancreas
Pathology
Channing J Der
Identification of synthetic lethal interactors in pancreatic cancer
Pancreas
Pathology